These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26769719)

  • 21. LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro.
    Sperduti S; Paradiso E; Anzivino C; Lazzaretti C; Limoncella S; D'Alessandro S; Roy N; Reggianini F; Ferrari T; Melli B; La Sala GB; Nicoli A; Daolio J; Villani MT; Tagliavini S; Trenti T; Potì F; Sandhowe R; Centonze C; Lispi M; Simoni M; Casarini L
    Hum Reprod; 2023 Jan; 38(1):103-112. PubMed ID: 36367827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
    Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
    Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A large observational data study supporting the PROsPeR score classification in poor ovarian responders according to live birth outcome.
    Lehert P; Arvis P; Avril C; Massin N; Parinaud J; Porcu G; Rongières C; Sagot P; Wainer R; D'Hooghe T
    Hum Reprod; 2021 May; 36(6):1600-1610. PubMed ID: 33860313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ala307Thr polymorphism of the follicle-stimulating hormone receptor (FSHR) gene is associated with the dose of recombinant FSH received during IVF/ICSI treatment.
    Dieamant F; Petersen CG; Vagnini LD; Petersen B; Ricci J; Nicoletti A; Zamara C; Oliani AH; Oliveira JBA; Franco JG
    JBRA Assist Reprod; 2023 Mar; 27(1):78-84. PubMed ID: 36995260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI.
    Paschalidou C; Anagnostou E; Mavrogianni D; Raouasnte R; Klimis N; Drakakis P; Loutradis D
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing.
    Bramble MS; Goldstein EH; Lipson A; Ngun T; Eskin A; Gosschalk JE; Roach L; Vashist N; Barseghyan H; Lee E; Arboleda VA; Vaiman D; Yuksel Z; Fellous M; Vilain E
    Hum Reprod; 2016 Apr; 31(4):905-14. PubMed ID: 26911863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
    Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
    Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expressions of aquaporin family in human luteinized granulosa cells and their correlations with IVF outcomes.
    Lee HJ; Jee BC; Kim SK; Kim H; Lee JR; Suh CS; Kim SH
    Hum Reprod; 2016 Apr; 31(4):822-31. PubMed ID: 26908840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of a novel long-acting recombinant follicle stimulating hormone agonist by fusing Fc to an FSH-β subunit.
    Zhang YL; Guo KP; Ji SY; Liu XM; Wang P; Wu J; Gao L; Jiang TQ; Xu T; Fan HY
    Hum Reprod; 2016 Jan; 31(1):169-82. PubMed ID: 26621853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does an FSH surge at the time of hCG trigger improve IVF/ICSI outcomes? A randomized, double-blinded, placebo-controlled study.
    Qiu Q; Huang J; Li Y; Chen X; Lin H; Li L; Yang D; Wang W; Zhang Q
    Hum Reprod; 2020 Jun; 35(6):1411-1420. PubMed ID: 32383771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of the T307A, N680S, and -29G>A single-nucleotide polymorphisms in the follicle-stimulating hormone receptor in Mexican subjects of Hispanic ancestry.
    García-Jiménez G; Zariñán T; Rodríguez-Valentín R; Mejía-Domínguez NR; Gutiérrez-Sagal R; Hernández-Montes G; Tovar A; Arechavaleta-Velasco F; Canto P; Granados J; Moreno-Macias H; Tusié-Luna T; Pellicer A; Ulloa-Aguirre A
    Reprod Biol Endocrinol; 2018 Oct; 16(1):100. PubMed ID: 30340493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous hCG and hMG commercial preparations result in different intracellular signalling but induce a similar long-term progesterone response in vitro.
    Riccetti L; Klett D; Ayoub MA; Boulo T; Pignatti E; Tagliavini S; Varani M; Trenti T; Nicoli A; Capodanno F; La Sala GB; Reiter E; Simoni M; Casarini L
    Mol Hum Reprod; 2017 Oct; 23(10):685-697. PubMed ID: 29044421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium.
    Sacchi S; Sena P; Degli Esposti C; Lui J; La Marca A
    J Assist Reprod Genet; 2018 Sep; 35(9):1703-1712. PubMed ID: 29974367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure.
    Motawi TMK; Rizk SM; Maurice NW; Maged AM; Raslan AN; Sawaf AH
    J Assist Reprod Genet; 2017 Dec; 34(12):1659-1666. PubMed ID: 28825151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.
    Moffat R; Hansali C; Schoetzau A; Ahler A; Gobrecht U; Beutler S; Raggi A; Sartorius G; De Geyter C
    Hum Reprod; 2021 Mar; 36(4):987-997. PubMed ID: 33367742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
    Lazaros L; Hatzi E; Xita N; Takenaka A; Sofikitis N; Zikopoulos K; Georgiou I
    J Reprod Med; 2013; 58(9-10):395-401. PubMed ID: 24050028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.
    Alviggi C; Conforti A; Santi D; Esteves SC; Andersen CY; Humaidan P; Chiodini P; De Placido G; Simoni M
    Hum Reprod Update; 2018 Sep; 24(5):599-614. PubMed ID: 29924306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.